Learn More
Medchemexpress LLC BGC-20-1531 free base | 736183-35-0 | 98.1% | 492.54 | 1 ML

Supplier: Medchemexpress LLC HY1984910MM/1ML
BGC-20-1531 (PGN 1531) free base is a potent and selective prostanoid EP4 receptor antagonist with a pKB of 7.6. It has potential for migraine headache research, competitively antagonizing PGE2-induced vasodilatation in human middle cerebral and meningeal arteries, while showing no effect on responses induced by PGE2 in coronary, pulmonary or renal arteries. In vivo, it causes a dose-dependent antagonism of PGE2-induced increase in canine carotid blood flow.
- Potent and selective prostanoid EP4 receptor antagonist.
- Potential for migraine headache research.
- Competitively antagonizes PGE2-induced vasodilatation of human middle cerebral and meningeal arteries.
- Shows no effect on responses induced by PGE2 on coronary, pulmonary or renal arteries.
- Causes a dose-dependent antagonism of PGE2-induced increase in canine carotid blood flow in vivo.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.